Compare Neurocrine Biosciences Inc (NBIX) vs Transocean Ltd (RIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Transocean Ltd — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Transocean Ltd trades at $5.23 (market cap $5.56B). The key difference: Neurocrine Biosciences Inc is far larger — about 3.1× Transocean Ltd's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Transocean Ltd nearer its low. Which is the better fit depends on your goals.
| NBIX | RIG | |
|---|---|---|
Market Cap | $17.40B | $5.56B |
Sector | Health | Technology |
52-Week High | $180.55 | $7.58 |
52-Week Low | $123.10 | $2.64 |
Enterprise Value | $16.49B | $10.50B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Transocean Ltd
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →
